Press releases https://presse.inserm.fr/en/feed/

Filter

Alzheimer’s: discovery of the involvement of new cells in the onset and progression of the disease

Patients with Alzheimer's disease have common biological alterations, including abnormal accumulation of the Tau protein in the brain. The mechanisms behind this abnormality may be on the verge of being elucidated. In a new study, a research team from Inserm, the University of Lille, and Lille University Hospital has revealed for the first time the role of tanycytes in the equation.

05 Mar 2026 | Neurosciences, cognitives sciences, neurology and psychiatry

When sleep apnea causes metabolic jet lag

Sleep apnea affects nearly one billion people worldwide and causes repeated episodes of oxygen deprivation during the night, known as intermittent hypoxia. A study conducted by scientists from the University of Grenoble Alpes, Inserm, and Grenoble Alpes University Hospital, published today in the journal Science Advances, shows that these episodes reorganize the liver's biological clock, altering the daily rhythms of its metabolic activity.

25 Feb 2026 | Circulation, metabolism, nutrition

In Paris, trees reduce mortality linked to heat waves

In Paris, districts with more vegetation have a lower risk of death during periods of high heat, while highly mineralized areas with few green spaces and a high potential for urban heat islands are the most exposed.The scientists emphasize the importance of developing vegetation in cities and better distributing green spaces among neighborhoods to protect the health of Parisians in the face of global warming.

16 Feb 2026 | Public health

COVID-19: discovery of renal and inflammatory markers predictive of disease severity

Researchers from Inserm and Paris Cité University, involved in the CORIMUNO-19 study promoted by AP-HP and funded by the Fondation pour la Recherche Médicale and ANRS Maladies infectieuses émergentes (ANRS MIE), have identified biological indicators that can predict 3-month mortality in patients hospitalised for COVID-19 pneumonia. Based on two renal and one immune markers obtained from a simple blood test, combined with patients' age, they have developed a new,...

28 Jan 2026 | Covid-19

Endocrine disruptors: exposure to methylparaben and bisphenol S during pregnancy may be associated with behavioral disorders in children

A study by Inserm, in collaboration with the CNRS, the University of Grenoble Alpes (UGA), the Grenoble Alpes University Hospital (CHU), and the Barcelona Institute for Global Health (ISGlobal), suggests there may be an association between exposure in the third trimester of pregnancy to two synthetic phenols, methylparaben and bisphenol S, commonly found in everyday products (food, cosmetics, plastics, etc.), and questionnaire scores that could suggest behavioral disorders in...

10 Dec 2025 | Public health

Diet and cancer: cabbages, essential allies of immunotherapy

A study conducted by Institut Curie and Inserm reveals that the presence of a compound present in cruciferous vegetables, indole-3-carbinol, is essential to make certain cancer treatments effective.

02 Dec 2025 | Cancer

Ultra-processed foods: documented negative health impacts and concrete proposals to limit population exposure

Two researchers from Inserm and one researcher from INRAE contributed to a series of three articles published on 19 November in The Lancet on the health consequences of consuming ultra-processed foods. The 43 international scientists who signed this series of articles propose the implementation of public health measures to limit the use of ultra-processed foods and improve nutrition worldwide.

19 Nov 2025 | Public health

Acute leukemia in children: exposure to certain air pollutants at birth could be associated with an increased risk

While the role of certain air pollutants is now recognized in some cancers in adults, it has not yet been established in the case of acute leukemia in children. A team of researchers from Inserm, in collaboration with Sorbonne Paris Nord University, Paris Cité University, INRAE and Swiss researchers, used data from the GEOCAP-Birth study based on the national registry of childhood cancer to assess the risk of acute...

05 Nov 2025 | Cancer Public health

Researchers develop an ultrasound probe capable of imaging an entire organ in 4D

For the first time, a team of Inserm researchers from the Physics for Medicine Institute Paris (Inserm/ESPCI Paris-PSL/CNRS) has succeeded in mapping the blood flow of an entire organ in animals (heart, kidney and liver) with great precision, in four dimensions: 3D + time. This new imaging technique, when applied to humans, could both improve our understanding of the circulatory system (veins, arteries, vessels and lymphatic system) and facilitate...

28 Oct 2025 | Health technologies

Air pollution in Europe: a groundbreaking assessment of a new measure of particulate exposure

A study conducted across 43 European countries by an international scientific team coordinated by Université Grenoble Alpes, in collaboration with the CNRS, Inserm, and the French National Research Institute for Sustainable Development (IRD), reveals that the ability of airborne particles to generate oxidative stress in the lungs (known as the oxidative potential, or OP) varies according to environmental type (urban, rural, industrial, etc.) and emission sources.

24 Oct 2025 | Europe Public health

International influence: Inserm highlights its scientific collaborations with the United Kingdom

Inserm continues to highlight its international collaborations in health research. In 2025, the Institute will focus on its fruitful collaboration with its British partners. The programme includes a day of scientific and institutional exchanges to be held on October 27, 2025, at the French Residence in London, attended by Prof. Didier Samuel, President and CEO of Inserm, and numerous partner institutions.

23 Oct 2025 | Institutionnel et évènementiel

Subretinal implant partially restores vision in AMD patients

Age-related macular degeneration (AMD) causes progressive vision loss in many elderly people, and no treatment is available for the so-called atrophic form of the disease. A neurostimulation system called Prima, including a subretinal implant, could change all that.

20 Oct 2025 | Neurosciences, cognitives sciences, neurology and psychiatry

fermer